➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Mallinckrodt
McKesson
Baxter
AstraZeneca
Colorcon
Johnson and Johnson

Last Updated: January 23, 2021

DrugPatentWatch Database Preview

Benztropine mesylate - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic sources for benztropine mesylate and what is the scope of freedom to operate?

Benztropine mesylate is the generic ingredient in two branded drugs marketed by Fresenius Kabi Usa, Hikma Farmaceutica, Luitpold, Navinta Llc, Akorn, Aspen Global Inc, Chartwell Rx, Epic Pharma Llc, Invagen Pharms, Lannett Co Inc, Leading Pharma Llc, Oxford Pharms, Pliva, Quantum Pharmics, Upsher Smith Labs, Usl Pharma, Vintage, and Merck, and is included in twenty-eight NDAs. Additional information is available in the individual branded drug profile pages.

There are seven drug master file entries for benztropine mesylate. Twenty-one suppliers are listed for this compound.

Drug Prices for benztropine mesylate

See drug prices for benztropine mesylate

Drug Sales Revenue Trends for benztropine mesylate

See drug sales revenues for benztropine mesylate

Recent Clinical Trials for benztropine mesylate

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Boehringer IngelheimPhase 2
National Institute of Allergy and Infectious Diseases (NIAID)Phase 2

See all benztropine mesylate clinical trials

Pharmacology for benztropine mesylate
Medical Subject Heading (MeSH) Categories for benztropine mesylate

US Patents and Regulatory Information for benztropine mesylate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Upsher Smith Labs BENZTROPINE MESYLATE benztropine mesylate TABLET;ORAL 040103-001 Dec 12, 1996 DISCN No No   Start Trial   Start Trial   Start Trial
Leading Pharma Llc BENZTROPINE MESYLATE benztropine mesylate TABLET;ORAL 090168-003 Nov 28, 2012 AA RX No No   Start Trial   Start Trial   Start Trial
Navinta Llc BENZTROPINE MESYLATE benztropine mesylate INJECTABLE;INJECTION 091525-001 Feb 5, 2013 AP RX No No   Start Trial   Start Trial   Start Trial
Upsher Smith Labs BENZTROPINE MESYLATE benztropine mesylate TABLET;ORAL 040103-002 Dec 12, 1996 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
McKesson
Medtronic
Express Scripts
Johnson and Johnson
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.